Xofigo Injection
Product Images NDC 50419-208

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Xofigo (NDC 50419-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

This is a chart/table showing the probability of survival for patients under treatment with Xofigo versus placebo over a period of 33 months. The number of patients at risk is listed for each time point.*

FDA Label Image

Vial Label Nist (Image 02)

This is a description of a medication with the NDC code 50419-208-01. The medication is a single-dose vial containing 6mL of sterile solution of radium Ra 223 dichloride injection manufactured for use in intravenous administration. The vial is intended for one-time use only, and any unused portion should be discarded. The solution has a strength of 1100 kBq/mL (30 microcurie/mL) and is produced by the CES facility located in Whippany, NJ 07981. Additionally, it has a strength of 6600 kBg/vial (178 microcurie/vial) at 5 AM (ST (12 noon CET) on reference date. The specific lot number for this medication is BXp: 85518682.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.